Centogene NV (Centogene NV) EBIT per Share : $-0.85 (TTM As of Jun. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Centogene NV EBIT per Share?

Centogene NV's EBIT per Share for the three months ended in Jun. 2023 was $0.00. Its EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2023 was $-0.85.

During the past 3 years, the average EBIT per Share Growth Rate was -4.70% per year. During the past 5 years, the average EBIT per Share Growth Rate was -49.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Centogene NV's EBIT per Share or its related term are showing as below:

CNTG' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -127.7 Med: -73.35 Max: -4.7
Current: -4.7

During the past 7 years, the highest 3-Year average EBIT per Share Growth Rate of Centogene NV was -4.70% per year. The lowest was -127.70% per year. And the median was -73.35% per year.

CNTG's 3-Year EBIT Growth Rate is ranked worse than
58.99% of 178 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.55 vs CNTG: -4.70

Centogene NV's EBIT for the three months ended in Jun. 2023 was $0.00 Mil.

Centogene NV EBIT per Share Historical Data

The historical data trend for Centogene NV's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Centogene NV EBIT per Share Chart

Centogene NV Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

EBIT per Share

Get a 7-Day Free Trial

-0.61

-1.26

-3.42

-2.85

-1.38

Centogene NV Quarterly Data
	Dec17	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Dec22	Jun23
EBIT per Share	Get a 7-Day Free Trial															-1.13	-0.49	-0.37	-	-

Centogene NV EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Centogene NV's EBIT per Share for the fiscal year that ended in Dec. 2022 is calculated as

	EBIT per Share		(A: Dec. 2022 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-37.103	/	26.811
=	-1.38

Centogene NV's EBIT per Share for the quarter that ended in Jun. 2023 is calculated as

	EBIT per Share		(Q: Jun. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	0	/	27.791
=	0.00

EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.85

Centogene NV (NAS:CNTG) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Centogene NV EBIT per Share Related Terms

Thank you for viewing the detailed overview of Centogene NV's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Centogene NV (Centogene NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Centogene NV (NAS:CNTG) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

39K:Germany

Address

Am Strande 7, Rostock, MV, DEU, 18055

Website

https://www.centogene.com

Centogene NV is a United States-based company focused on transforming clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. The company operates in three segments: pharmaceutical, diagnostics, and COVID-19. Its pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. Its clinical diagnostics segment provides targeted genetic sequencing and diagnostics services to patients.